Mindray Medical International Announces Second Quarter 20...(to expand its presence internationally t...)

Date:9/3/2008

to expand its presence internationally through setting up offices and locating customer support and sales representatives in global markets, particularly in North America, Europe and Latin America," added Mr. Li Xiting, Mindray's president and co-chief executive officer. "In addition to our geographic expansion, we have increased the range of products available in the U.S. with FDA clearance on five new products in the first half of 2008. With our world-class R&D team and strict financial discipline, we have continued to drive down production costs and enhance overall operating efficiency to achieve higher year-over-year growth in our operating profit than in revenues during the quarter for our China-based operations, excluding DPM. Our ability to continue to reduce manufacturing costs and deliver cost- efficient R&D will be key to realizing expected synergies from the recent acquisition."

Financial Results for Second Quarter 2008

Mindray reported net revenues of US$145.7million for the second quarter 2008, a 99.5% increase from US$73.0 million in the second quarter 2007.

Net revenues generated in international markets in the second quarter 2008 increased 139.0% to US$87.8 million from US$36.7 million in the second quarter 2007.

Net revenues generated in China in the second quarter 2008 increased 59.4% US$57.9 million from US$36.3 million in the second quarter 2007.

Performance by Segment

Patient Monitoring & Life Support Products: Patient monitoring & life support products segment, including DPM revenues, increased 157.7 % to US$67.0 million from US$26.0 million in the second quarter 2007. The patient monitoring & life support products segment contributed 46.5% to total net segment revenues in the second quarter 2008.

In-Vitro Diagnostic Products: In-vitro diagnostic products segment revenues increased 62.3% to US$34.9 million from US$21.5 million in the second quarter 2007. The in-vitro diagnostic products segment c
'/>"/>

SOURCE Mindray Medical International Limited Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces First Quarter 2008 Results
6. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. BioMS Medical announces its intention to renew a normal course issuer bid